ArticleScientific reports2021
Denosumab versus romosozumab for postmenopausal osteoporosis treatment.
Tomonori Kobayakawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
56 papers cite it
this paperpooled ittrialcites it
ArticleScientific reports2021
Tomonori Kobayakawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.